Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma
Clinical trial NCT02876978 · UNKNOWN
Trial details
- NCT number
- NCT02876978
- Sponsor
- CARsgen Therapeutics Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.